AKT1 and kidney cancer: The dysregulation of MET, another tyrosine kinase receptor activated by the hepatocyte growth factor (HGF), induces the activation of both the PI3K-Akt and Ras/MAPK pathways which promote cell growth and metastasis in kidney cancer [26].